AARP Executive Vice President and Chief Advocacy and Engagement Officer Nancy LeaMond issued the following statement related to comments about changes at the Social Security Administration (SSA).
The acting head of the Social Security Administration (SSA) on Feb. 19 sought to reassure older Americans that payments will continue as usual and that Department of Government Efficiency (DOGE) staff have limited access to its systems, amid growing concerns over service disruptions and the privacy of beneficiaries’ personal data.
Older Americans depend on services provided by the Social Security Administration, whether it be over the phone, online, or face-to-face at local field offices.
The names of the first 10 Medicare drugs whose prices the federal government will negotiate directly with manufacturers were released Aug. 29. Popular but pricey blood thinners, diabetes medications, cancer treatments make historic list.
“AARP Arizona is thrilled the Arizona Corporation Commission adopted our recommendations in the APS rate case order issued today. AARP Arizona has been focused on the issues surrounding the previous rate case, which was issued in 2017. AARP Arizona felt strongly enough during those proceedings to be one of only two groups to refuse to sign on to the settlement agreement. With today’s decision, AARP has been vindicated in our decision, and glad to know that then and now we will always fight for the 50+” Dana Kennedy, State Director for AARP Arizona said.
Medicare changes every year, which means it can get a little complicated when trying to understand what’s new for you. Join us for a free webinar where we’ll discuss the key takeaways from this year’s Medicare changes and what they may mean for your benefits.
Every day, some 48 million Americans help parents, spouses and other loved ones with medical care, meals, bathing, dressing, chores and much more. They do it out of love, not for pay.
PHOENIX, Arizona—AARP Executive Vice President and Chief Advocacy & Engagement Officer Nancy A. LeaMond issued the following statement reacting to the Build Back Better framework’s failure to lower prescription drug prices. LeaMond said: